Concord Drugs share price
You have to be logged in to add this to Watchlist.- ₹81.00(2.00%)May 15, 2026 14:57:25 PM IST
- NSE
- BSE
- Vol : 1.24 K (NSE + BSE)Last 20 day avg : 4.88 K
Concord Drugs is trading 2.00% upper at Rs 81.00 as compared to its last closing price. Concord Drugs has been trading in the price range of 83.39 & 80.60. Concord Drugs has given -3.72% in this year & -5.41% in the last 5 days. Concord Drugs has TTM P/E ratio 162.40 as compared to the sector P/E of 24.31.The company posted a net profit of 0.22 Crores in its last quarter.Listed peers of Concord Drugs include Sun Pharmaceutical Industries (0.90%), Divi's Laboratories (-2.41%), Torrent Pharmaceuticals (-0.52%).The Mutual Fund holding in Concord Drugs was at -% in . The MF holding has - from the last quarter. The FII holding in Concord Drugs was at -% in . The FII holding has - from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on May 16, 2026, 09:03 PM UTC
- BetaMedium volatility0.98Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry0.56The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- P/BHigher than historical values2.33The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/EHigher than historical values156.36Price-to-earnings ratio based on trailing 12-month earnings
- PEG RatioIndicates undervaluation-3.63The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | Bullish | 1,879.90 | 0.90 | 4,51,076.67 | 35.40 | 5.64 | 0.97 | 0.50 |
| Divi's Laboratories | Bullish | 6,755.00 | -2.41 | 1,78,679.99 | 74.75 | 10.96 | 0.49 | 0.01 |
| Torrent Pharmaceuticals | Bullish | 4,386.00 | -0.52 | 1,48,148.92 | 73.03 | 18.55 | 0.84 | 17.62 |
| Lupin | Neutral | 2,273.90 | 0.71 | 1,04,095.41 | 31.95 | 6.21 | 0.51 | 11.80 |
| Dr Reddy's Laboratories | Bullish | 1,336.95 | 2.62 | 1,11,584.24 | 17.92 | 3.02 | 0.66 | 2.34 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-02-14 | Quarterly Results |
| 2025-11-13 | Quarterly Results |
| 2025-08-08 | Quarterly Results |
| 2025-05-23 | Audited Results |
| 2025-03-17 | Preferential Issue of shares & Others |
- IndustryBiotechnology & Drugs
- ISININE858L01010
- BSE Code538965
- NSE Code
Concord Drugs is trading at 81.00 as on Fri May 15 2026 09:27:25. This is 2.00% upper as compared to its previous closing price of 79.41.
The market capitalization of Concord Drugs is 104.62 Cr as on Fri May 15 2026 09:27:25.
The 52 wk high for Concord Drugs is 92.52 whereas the 52 wk low is 29.00
Concord Drugs can be analyzed on the following key metrics -
- TTM P/E: 162.40
- Sector P/E: 24.31
- Dividend Yield: 0.00%
- D/E ratio: -
Concord Drugs reported a net profit of 0.34 Cr in 2025.
EQUITY QUICK LINKS
Concord Drugs QUICK LINKS
FROM MARKETS
RELATED LINKS
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.